Bruce & Co portfolio · Q4 2025
Bruce & Co., Inc. · CIK 0001358331 ·13F filings on SEC EDGAR
In Q4 2025, Bruce & Co., Inc. reported 39 positions worth $322.5M. Its largest holding was ABBV at 8.7% of the portfolio, and the top 10 made up 64%. This is the earliest quarter available here, so changes are not shown.
Portfolio map
Each box is a position sized by its value. There is no previous quarter here to compare changes.
Holdings
Click a holding to see its price chart with the quarters the investor bought or sold.
| Name | Weight | Avg. cost (est.) | Latest price | Gain/loss | Value |
|---|---|---|---|---|---|
ABBV ABBVIE INC | 8.68% | $88.64* | $261.59 | +195.1% | $32M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AER AERCAP HOLDINGS NV | 8.18% | $96.45 | $143.52 | +48.8% | $26.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ALL ALLSTATE CORP | 8.10% | $73.67* | $221.86 | +201.1% | $27.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
302571104 Nextera Energy | 7.72% | $86.42* | $75.74 | -12.4% | $23.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
UHAL.B U-HAUL HOLDING CO-NON VOTING | 6.55% | $55.44 | $52.85 | -4.7% | $23.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
589331107 Merck | 6.29% | — | $145.31 | — | $28M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
DUK DUKE ENERGY CORP | 5.66% | $80.86* | $114.01 | +41.0% | $17.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
XEL XCEL ENERGY INC | 4.45% | $42.00* | $70.48 | +67.8% | $13.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ABT ABBOTT LABORATORIES | 4.42% | $46.38* | $98.83 | +113.1% | $11.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
T AT&T INC | 4.03% | $22.18 | $24.40 | +10.0% | $12.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CMS CMS ENERGY CORP | 3.38% | $42.65* | $63.08 | +47.9% | $9.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
IIIN INSTEEL INDUSTRIES INC | 3.37% | $26.79 | $29.13 | +8.7% | $10M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AAPL APPLE INC | 3.28% | $62.13 | $333.02 | +436.0% | $13M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
NEM NEWMONT CORP | 3.10% | $39.70 | $115.34 | +190.5% | $11.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
VICR VICOR CORP | 3.06% | $43.74 | $288.94 | +560.5% | $26M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AVA AVISTA CORP | 2.41% | $40.77* | $35.09 | -13.9% | $7.1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
PFE PFIZER INC | 2.10% | $31.17* | $28.52 | -8.5% | $7.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
BG BUNGE GLOBAL SA | 1.93% | $100.31 | $106.95 | +6.6% | $7.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ADM ARCHER-DANIELS-MIDLAND CO | 1.78% | $61.28 | $79.38 | +29.5% | $7.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
KOD KODIAK SCIENCES INC | 1.43% | $6.20 | $94.80 | +1,429.0% | $15.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
868459108 SUPERNUS PHARMACEUTICALS | 1.27% | $28.12* | $43.04 | +53.0% | $3.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
DAR DARLING INGREDIENTS INC | 1.18% | $47.28 | $60.71 | +28.4% | $6.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
UHAL U-HAUL HOLDING CO | 1.16% | $340.53* | $60.17 | -82.3% | $4.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CC CHEMOURS CO/THE | 0.91% | $13.11 | $13.57 | +3.5% | $3.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
RLI RLI CORP | 0.81% | $107.21* | $55.31 | -48.4% | $2.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
LYB LYONDELLBASELL INDU-CL A | 0.81% | $54.92 | $57.47 | +4.6% | $3.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
LLY ELI LILLY & CO | 0.67% | $772.00 | $1,157.08 | +49.9% | $2.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
PSNL PERSONALIS INC | 0.58% | $2.30 | $16.28 | +607.8% | $3.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
FOCL EDAP TMS SA -ADR | 0.45% | $4.02* | $4.47 | +11.2% | $2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
82968B103 SIRIUS XM HOLDINGS INC | 0.35% | $3.95* | $25.88 | +555.2% | $1.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
MNKD MANNKIND CORP | 0.34% | $3.84 | $3.90 | +1.6% | $760.8K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
044209104 Ashland | 0.27% | $109.96* | $67.92 | -38.2% | $1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
91911K102 Bausch Health | 0.27% | $18.86 | $5.83 | -69.1% | $722.9K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
VTRS VIATRIS INC | 0.22% | $13.52 | $17.72 | +31.1% | $1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
FATE FATE THERAPEUTICS INC | 0.22% | $3.22 | $2.37 | -26.5% | $1.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
VG VENTURE GLOBAL INC-CL A | 0.21% | $10.30 | $12.64 | +22.7% | $1.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
WEC WEC ENERGY GROUP INC | 0.13% | $78.46 | $100.78 | +28.4% | $397.6K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CRBU CARIBOU BIOSCIENCES INC | 0.12% | $3.73 | $1.27 | -66.0% | $317.5K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
MASS 908 DEVICES INC | 0.11% | $7.62 | $12.34 | +61.9% | $842.6K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price. * Held since before Mar 31, 2016, when our collected history starts, so the average starts from that quarter's price.
SEC filings for Q4 2025
- 13F-HR 0001104659-26-015254 · accepted Feb 13, 2026, 21:28 UTC